Bortezomib- and carfilzomib-resistant multiple myeloma cells generated in vitro match the molecular hallmarks of bortezomib-resistant primary myeloma cells, but differ in their sensitivity to bortezomib, carfilzomib and novel proteasome inhibiting drugs | Publicación